Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 24, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Traumatic Brain Injury
Interventions
DRUG

Baricitinib 4 MG

Baricitinib with be be administrated orally (or crushed for nasogastric tube delivery) and given daily at the dosage of 4mg for consecutive 14 days

OTHER

Standard treatment

Patients will receive standard treatment and care according to the current management guidelines for traumatic brain injury.

Trial Locations (1)

710038

RECRUITING

Tandu Hospital, Fourth Military Medical University, Xi'an

All Listed Sponsors
collaborator

Qianxian People's Hospital

UNKNOWN

collaborator

Chongqing Hospital of PAP

UNKNOWN

collaborator

Weinan Central Hospital

OTHER

collaborator

Second Affiliated Hospital of Xi'an Jiaotong University

OTHER

collaborator

the 987th Hospital of Chinese People's Liberation Army Joint Logistic Support Force

UNKNOWN

lead

Tang-Du Hospital

OTHER